Medicinal chemistry

Medicinal Chemistry

Medicinal Chemistry is a research theme within the Monash Institute of Pharmaceutical Sciences (MIPS).

Research areas

Find a researcher



Contact us

+61 3 9903 9614
nicki.penny@monash.edu

Find a PhD project

We're looking for the brightest biomedical science, pharmaceutical science and pharmacy talent to join our ambitious, curious and groundbreaking research teams. We want to change the world and you can help us.

See the latest news

MIPS researcher founding scientist of new biotech company launched with AUD$10m investment

Ankere Therapeutics is dedicated to the development of new therapies that target inflammatory diseases, particularly those affecting the lung.
Industry & partnerships

From concept to clinic: How Monash researchers developed a novel antibiotic candidate to tackle deadly bacterial ‘superbugs’

Deemed a global health crisis, Gram-negative bacteria can cause life-threatening infections including pneumonia, bloodstream infections, urinary tract infections, peritonitis and meningitis.
Medicine & health

Monash forms partnership with Indian biotech to accelerate early drug discovery projects

Monash University has entered into a partnership with Indian drug discovery biotech, Integral BioSciences Pvt. Ltd, to accelerate the translation of early drug discovery projects towards licensing, preclinical development, IND and clinical trials.
Industry & partnerships

MIPS researcher receives NHMRC Development Grant funding

Professor Jonathan Baell is one of the two Monash University researchers that have received federal government funding to progress their projects towards the development of treatments for blocked arteries, and intravenous drug delivery in stroke
Medicine & health

Monash University and partners awarded Global Innovation Linkages Program grant to boost global demand for imaging agents in disease diagnostics

The Commonwealth Government’s GILP has invested $1 million to establish a Research & Development manufacturing hub for the production and commercialisation of new [18F]-PET imaging agents, as part of a collaboration being led by Monash
Research

Scientists tackle the issue of “nuisance compounds”

An international consortium of world-leading scientific investigators, including Monash University, are developing a “nuisance compound” toolset, which will enable global researchers to distinguish the good from the bad when screening
Research
Young person placing medication in the palms of elderly person in long blue sleeves

MIPS researchers receive MRFF funding to accelerate discovery research projects

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are leading, or playing an integral role, in a number of projects which have received funding from the Commonwealth Government’s Medical Research Future Fund (MRFF).
Research

Next-gen antibiotic developed by Monash University enters clinical trials

In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria - also known as ‘superbugs’ - a new antibiotic (QPX9003) discovered by Monash University researchers has entered
Research

Monash University drug researchers discover potent class of molecules that kills malaria parasite

A world-leading team of antimalarial researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) have discovered a new class of molecules capable of killing Plasmodium falciparum, the parasite that causes malaria in humans through the
Research